Name: Recombinant Human Triggering Receptor Expressed on Myeloid Cells 2
Price: Inquiry

- Overview
  - TREM2 Human Recombinant produced in E. Coli is a single, non-glycosylated polypeptide chain containing 181 amino acids (19-161 a.a) and having a molecular mass of 20.4kDa. TREM2 is fused to a 38 amino acid His-tag at N-terminus & purified by proprietary chromatographic techniques. TREM2 is a membrane protein that forms a receptor signaling complex with TYROBP. TREM2 may be involved in chronic inflammation by triggering the production of constitutive inflammatory cytokines. Defects in the TREM2 gene are a source of polycystic lipomembranous osteodysplasia with sclerosing leukoencephalopathy (PLOSL).
    
    Please contact us at for specific academic pricing.
- Properties
  - Protein Name
    
    Triggering receptor expressed on myeloid cells 2, Triggering receptor expressed on monocytes 2, TREM-2, TREM2, Trem2a, Trem2b, Trem2c.
    
    Source
    
    E. coli
    
    Type
    
    Recombinant Proteins
    
    Purification
    
    Greater than 90.0% as determined by SDS-PAGE.
    
    Formulation
    
    TREM2 protein solution (0.25mg/ml) contains 20mM Tris-HCl buffer (pH 8.0), 0.15M NaCl, 10% glycerol and 1mM DTT.
    
    Storage
    
    Store at 4°C if entire vial will be used within 2-4 weeks. Store, frozen at -20°C for longer periods of time. For long term storage it is recommended to add a carrier protein (0.1% HSA or BSA). Avoid multiple freeze-thaw cycles.
    
    * For Research Use Only. Not for use in diagnostic/therapeutics procedures.

Recombinant Human Triggering Receptor Expressed on Myeloid Cells 2

Recombinant Human Triggering Receptor Expressed on Myeloid Cells 2

We Also Recommend

Recombinant Human Cardiac Troponin-I

Recombinant Human TP53 Regulated Inhibitor Of Apoptosis 1

Recombinant Human Tripartite Motif Containing 21 (RO52)